Stocks and Investing Stocks and Investing
Tue, December 13, 2022
[ 12:00 AM ] - WOPRAI
Christopher Raymond Maintained (AMGN) at Buy with Increased Target to $299 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Anthony Powell Maintained (AMH) at Buy with Decreased Target to $37 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Steven Alexopoulos Maintained (CFR) at Buy with Decreased Target to $155 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Mihir Bhatia Downgraded (SYF) to Hold on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
W. Andrew Carter Initiated (SWIM) at Hold and Held Target at $3 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Roanna Ruiz Initiated (SPRY) at Buy and Held Target at $14 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Elizabeth Porter Maintained (SPT) at Hold with Increased Target to $63 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Barker Initiated (SQ) at Buy and Held Target at $93 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Ygal Arounian Initiated (SQSP) at Hold and Held Target at $21 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Samantha Semenkow Initiated (SNSE) at Strong Buy and Held Target at $6 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Steven Alexopoulos Maintained (SNV) at Buy with Decreased Target to $43 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Yuqian Ding Maintained (XPEV) at Strong Buy with Decreased Target to $15 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Ronald Josey Initiated (XMTR) at Strong Buy and Held Target at $55 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Anna Andreeva Initiated (WSM) at Hold on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Steven Alexopoulos Maintained (VLY) at Hold with Decreased Target to $12 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Thomas Catherwood Maintained (VRE) at Strong Buy with Decreased Target to $22 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Ygal Arounian Initiated (VRSN) at Strong Buy and Held Target at $243 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Guy Hardwick Initiated (VNT) at Hold and Held Target at $21 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Christopher Mcgratty Downgraded (AMTB) to Hold and Held Target at $32 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Paul Silverstein Maintained (ANET) at Buy with Increased Target to $212 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Ygal Arounian Initiated (ANGI) at Strong Buy and Held Target at $2.6 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Steven Alexopoulos Maintained (WAL) at Hold with Decreased Target to $65 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Ygal Arounian Initiated (W) at Strong Buy and Held Target at $50 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Steven Alexopoulos Maintained (WBS) at Hold with Decreased Target to $50 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Steve Frankel Maintained (UTI) at Strong Buy with Decreased Target to $9 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Alexander Paris Maintained (UTI) at Buy with Decreased Target to $10 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Eric Martinuzzi Maintained (UTI) at Strong Buy with Decreased Target to $10 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
David Konrad Upgraded (USB) to Buy and Increased Target to $58 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Guy Hardwick Initiated (APH) at Buy and Held Target at $47 on, Dec 13th, 2022
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (ARQT) at Buy with Increased Target to $51 on, Dec 13th, 2022

Vikram Purohit Maintained (ARQT) at Buy with Increased Target to $51 on, Dec 13th, 2022


Published on 2024-10-28 00:32:36 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Increased Target from $49 to $51 on, Dec 13th, 2022.

Vikram has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram

  • Sean Kim of "JonesTrading" Initiated at Strong Buy and Held Target at $54 on, Thursday, September 22nd, 2022
  • Serge Belanger of "Needham" Initiated at Strong Buy and Held Target at $46 on, Wednesday, September 7th, 2022
Contributing Sources